Literature DB >> 2716281

Studies of mechanisms and protective maneuvers in myoglobinuric acute renal injury.

R A Zager1.   

Abstract

To explore why urine pH affects myoglobin (M)-induced renal injury, rats were infused with M under aciduric (NH4Cl) or alkalinuric (KHCO3) conditions with or without additional solute loading. Acute renal M retention (R) was highly pH dependent (pH 5.77, 68% R; pH 6.45, 49% R; pH 8.0, 28% R), the % R positively affecting the severity of renal injury (azotemia, proximal tubular necrosis, M casts, medullary vascular congestion, assessed 3 and/or 24 hours later). However, nonreabsorbable, nonalkalinizing salts (SO4) equiosmolar to KHCO3 decreased M retention to 21% and produced comparable functional/morphologic protection as HCO3. Equiosmolar reabsorbable salt (NaCl) did not decrease M retention (67%) or confer significant protection. M, when suspended in urine, but not in 0.45% NaCl, was highly acid precipitable (73% versus 10%). Electrophoretic/solubility studies indicated that M, not hematin, precipitated. M infusion did not decrease renal cortical soluble thiol groups (principally glutathione) or raise malondialdehyde concentrations at a time that tubular damage was apparent. Neither deferoxamine nor 2 hydroxyl radical scavengers (dimethylthiouria, Na benzoate) conferred significant functional/morphologic protection. These results indicate that aciduria promotes myoglobinuric-renal injury by acutely trapping M within the kidney, not by causing hematin formation. HCO3 protects by increasing urinary M solubility and by providing nonreabsorbed solute, both facilitating its excretion. Fe-stimulated hydroxyl radical formation does not appear to be necessary for M to cause renal damage.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2716281

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  37 in total

1.  Preventive effects of hyperbaric oxygen treatment on glycerol-induced myoglobinuric acute renal failure in rats.

Authors:  Suleyman Ayvaz; Burhan Aksu; Mehmet Kanter; Hafize Uzun; Mustafa Erboga; Alkin Colak; Umit Nusret Basaran; Mehmet Pul
Journal:  J Mol Histol       Date:  2012-02-07       Impact factor: 2.611

2.  Protocols cure diseases, not patients: flaccid paresis in post-NSTEMI statin treatment.

Authors:  Javier Rosada; Eleni Rebelos; Stefania Petruccelli; Marco Taddei
Journal:  BMJ Case Rep       Date:  2015-04-22

Review 3.  Volume Resuscitation in Patients With High-Voltage Electrical Injuries.

Authors:  Derek M Culnan; Kelley Farner; Genevieve H Bitz; Karel D Capek; Yiji Tu; Carlos Jimenez; William C Lineaweaver
Journal:  Ann Plast Surg       Date:  2018-03       Impact factor: 1.539

4.  Corticosteroids in the treatment of alcohol-induced rhabdomyolysis.

Authors:  James W Antoon; Chayan Chakraborti
Journal:  Mayo Clin Proc       Date:  2011-10       Impact factor: 7.616

5.  Selenium inhibits renal oxidation and inflammation but not acute kidney injury in an animal model of rhabdomyolysis.

Authors:  Anu Shanu; Ludwig Groebler; Hyun Bo Kim; Sarah Wood; Claire M Weekley; Jade B Aitken; Hugh H Harris; Paul K Witting
Journal:  Antioxid Redox Signal       Date:  2012-10-16       Impact factor: 8.401

6.  Specific macrophage subtypes influence the progression of rhabdomyolysis-induced kidney injury.

Authors:  Julie Belliere; Audrey Casemayou; Laure Ducasse; Alexia Zakaroff-Girard; Frédéric Martins; Jason S Iacovoni; Céline Guilbeau-Frugier; Bénédicte Buffin-Meyer; Bernard Pipy; Dominique Chauveau; Joost P Schanstra; Jean-Loup Bascands
Journal:  J Am Soc Nephrol       Date:  2014-09-30       Impact factor: 10.121

7.  Community acquired methicillin-resistant Staphylococcus aureus pneumonia leading to rhabdomyolysis: a case report.

Authors:  Poorani Nallam Goundan; Anurag Mehrotra; Deepa Mani; Indumathy Varadarajan
Journal:  Cases J       Date:  2010-02-14

8.  Rhabdomyolysis and myoglobinuria associated with violent exercise and alcohol abuse: report of two cases.

Authors:  T Zajaczkowski; G Potjan; E Wojewski-Zajaczkowski; W Straube
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

9.  Inorganic iron effects on in vitro hypoxic proximal renal tubular cell injury.

Authors:  R A Zager; B A Schimpf; C R Bredl; D J Gmur
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

10.  Combined mannitol and deferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress. Mechanistic and therapeutic implications.

Authors:  R A Zager
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.